<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title>Curr Top Med Chem[TA]</title><link>http://www.unboundmedicine.com/medline/ebm/journal/Curr_Top_Med_Chem</link><description>Unbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.</description><language>en-us</language><copyright>Unbound Medicine, Inc.</copyright><item><title>TGR5 as a Therapeutic Target for Treating Obesity.</title><link>http://www.unboundmedicine.com/medline/ebm/record/20180762/full_citation/TGR5_as_a_Therapeutic_Target_for_Treating_Obesity_</link><description>Zhong M <br/><span class="title">TGR5 as a Therapeutic Target for Treating Obesity. [JOURNAL ARTICLE]</span><br/><span class="source" title="Current topics in medicinal chemistry">Curr Top Med Chem 2010 Feb 25.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/20180762/abstract/TGR5_as_a_Therapeutic_Target_for_Treating_Obesity_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/20180762/full_citation/TGR5_as_a_Therapeutic_Target_for_Treating_Obesity_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/20180762/TGR5_as_a_Therapeutic_Target_for_Treating_Obesity_">Find Related Articles</a> </description></item><item><title>AMPK Activators as Novel Therapeutics for Type 2 Diabetes.</title><link>http://www.unboundmedicine.com/medline/ebm/record/20180761/full_citation/AMPK_Activators_as_Novel_Therapeutics_for_Type_2_Diabetes_</link><description>Yu LF, Qiu BY, Nan FJ, et al. <br/><span class="title">AMPK Activators as Novel Therapeutics for Type 2 Diabetes. [JOURNAL ARTICLE]</span><br/><span class="source" title="Current topics in medicinal chemistry">Curr Top Med Chem 2010 Feb 25.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/20180761/abstract/AMPK_Activators_as_Novel_Therapeutics_for_Type_2_Diabetes_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/20180761/full_citation/AMPK_Activators_as_Novel_Therapeutics_for_Type_2_Diabetes_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/20180761/AMPK_Activators_as_Novel_Therapeutics_for_Type_2_Diabetes_">Find Related Articles</a> </description></item><item><title>Renal Sodium-Dependent Glucose Cotransporter 2 (SGLT2) Inhibitors for New Anti-Diabetic Agent.</title><link>http://www.unboundmedicine.com/medline/ebm/record/20180760/full_citation/Renal_Sodium_Dependent_Glucose_Cotransporter_2__SGLT2__Inhibitors_for_New_Anti_Diabetic_Agent_</link><description>Nomura S <br/><span class="title">Renal Sodium-Dependent Glucose Cotransporter 2 (SGLT2) Inhibitors for New Anti-Diabetic Agent. [JOURNAL ARTICLE]</span><br/><span class="source" title="Current topics in medicinal chemistry">Curr Top Med Chem 2010 Feb 25.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/20180760/abstract/Renal_Sodium_Dependent_Glucose_Cotransporter_2__SGLT2__Inhibitors_for_New_Anti_Diabetic_Agent_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/20180760/full_citation/Renal_Sodium_Dependent_Glucose_Cotransporter_2__SGLT2__Inhibitors_for_New_Anti_Diabetic_Agent_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/20180760/Renal_Sodium_Dependent_Glucose_Cotransporter_2__SGLT2__Inhibitors_for_New_Anti_Diabetic_Agent_">Find Related Articles</a> </description></item><item><title>Recent Advances in Stearoyl-CoA Desaturase 1 Inhibitors for Dyslipidemia and Obesity.</title><link>http://www.unboundmedicine.com/medline/ebm/record/20180759/full_citation/Recent_Advances_in_Stearoyl_CoA_Desaturase_1_Inhibitors_for_Dyslipidemia_and_Obesity_</link><description>Liu G <br/><span class="title">Recent Advances in Stearoyl-CoA Desaturase 1 Inhibitors for Dyslipidemia and Obesity. [JOURNAL ARTICLE]</span><br/><span class="source" title="Current topics in medicinal chemistry">Curr Top Med Chem 2010 Feb 25.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/20180759/abstract/Recent_Advances_in_Stearoyl_CoA_Desaturase_1_Inhibitors_for_Dyslipidemia_and_Obesity_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/20180759/full_citation/Recent_Advances_in_Stearoyl_CoA_Desaturase_1_Inhibitors_for_Dyslipidemia_and_Obesity_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/20180759/Recent_Advances_in_Stearoyl_CoA_Desaturase_1_Inhibitors_for_Dyslipidemia_and_Obesity_">Find Related Articles</a> </description></item><item><title>Anti-Diabetic Agents from Natural Products-An Update from 2004 to 2009.</title><link>http://www.unboundmedicine.com/medline/ebm/record/20180758/full_citation/Anti_Diabetic_Agents_from_Natural_Products_An_Update_from_2004_to_2009_</link><description>Qi LW, Liu EH, Chu C, et al. <br/><span class="title">Anti-Diabetic Agents from Natural Products-An Update from 2004 to 2009. [JOURNAL ARTICLE]</span><br/><span class="source" title="Current topics in medicinal chemistry">Curr Top Med Chem 2010 Feb 25.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/20180758/abstract/Anti_Diabetic_Agents_from_Natural_Products_An_Update_from_2004_to_2009_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/20180758/full_citation/Anti_Diabetic_Agents_from_Natural_Products_An_Update_from_2004_to_2009_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/20180758/Anti_Diabetic_Agents_from_Natural_Products_An_Update_from_2004_to_2009_">Find Related Articles</a> </description></item><item><title>The Akt/PKB Family of Protein Kinases: A Review of Small Molecule Inhibitors and Progress Towards Target Validation: A 2009 Update.</title><link>http://www.unboundmedicine.com/medline/ebm/record/20180757/full_citation/The_Akt/PKB_Family_of_Protein_Kinases:_A_Review_of_Small_Molecule_Inhibitors_and_Progress_Towards_Target_Validation:_A_2009_Update_</link><description>Lindsley CW <br/><span class="title">The Akt/PKB Family of Protein Kinases: A Review of Small Molecule Inhibitors and Progress Towards Target Validation: A 2009 Update. [JOURNAL ARTICLE]</span><br/><span class="source" title="Current topics in medicinal chemistry">Curr Top Med Chem 2010 Feb 25.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/20180757/abstract/The_Akt/PKB_Family_of_Protein_Kinases:_A_Review_of_Small_Molecule_Inhibitors_and_Progress_Towards_Target_Validation:_A_2009_Update_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/20180757/full_citation/The_Akt/PKB_Family_of_Protein_Kinases:_A_Review_of_Small_Molecule_Inhibitors_and_Progress_Towards_Target_Validation:_A_2009_Update_">Full Citation</a></description></item><item><title>Metabotropic Glutamate Receptors as Therapeutic Targets for Cognitive Disorders.</title><link>http://www.unboundmedicine.com/medline/ebm/record/20170472/full_citation/Metabotropic_Glutamate_Receptors_as_Therapeutic_Targets_for_Cognitive_Disorders_</link><description>Gravius A, Pietraszek M, Dekundy A, et al. <br/><span class="title">Metabotropic Glutamate Receptors as Therapeutic Targets for Cognitive Disorders. [JOURNAL ARTICLE]</span><br/><span class="source" title="Current topics in medicinal chemistry">Curr Top Med Chem 2010 Feb 18.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/20170472/abstract/Metabotropic_Glutamate_Receptors_as_Therapeutic_Targets_for_Cognitive_Disorders_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/20170472/full_citation/Metabotropic_Glutamate_Receptors_as_Therapeutic_Targets_for_Cognitive_Disorders_">Full Citation</a></description></item><item><title>Histamine H(3) Antagonists for Treatment of Cognitive Deficits in CNS Diseases.</title><link>http://www.unboundmedicine.com/medline/ebm/record/20166960/full_citation/Histamine_H_3__Antagonists_for_Treatment_of_Cognitive_Deficits_in_CNS_Diseases_</link><description>Raddatz R, Tao M, Hudkins RL <br/><span class="title">Histamine H(3) Antagonists for Treatment of Cognitive Deficits in CNS Diseases. [JOURNAL ARTICLE]</span><br/><span class="source" title="Current topics in medicinal chemistry">Curr Top Med Chem 2010 Feb 18.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/20166960/abstract/Histamine_H_3__Antagonists_for_Treatment_of_Cognitive_Deficits_in_CNS_Diseases_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/20166960/full_citation/Histamine_H_3__Antagonists_for_Treatment_of_Cognitive_Deficits_in_CNS_Diseases_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/20166960/Histamine_H_3__Antagonists_for_Treatment_of_Cognitive_Deficits_in_CNS_Diseases_">Find Related Articles</a> </description></item><item><title>Neuronal Nicotinic Acetylcholine Receptors - Targets for the Development of Drugs to Treat Cognitive Impairment Associated with Schizophrenia and Alzheimer's Disease.</title><link>http://www.unboundmedicine.com/medline/ebm/record/20166959/full_citation/Neuronal_Nicotinic_Acetylcholine_Receptors___Targets_for_the_Development_of_Drugs_to_Treat_Cognitive_Impairment_Associated_with_Schizophrenia_and_Alzheimer's_Disease_</link><description>Haydar SN, Dunlop J <br/><span class="title">Neuronal Nicotinic Acetylcholine Receptors - Targets for the Development of Drugs to Treat Cognitive Impairment Associated with Schizophrenia and Alzheimer's Disease. [JOURNAL ARTICLE]</span><br/><span class="source" title="Current topics in medicinal chemistry">Curr Top Med Chem 2010 Feb 18.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/20166959/abstract/Neuronal_Nicotinic_Acetylcholine_Receptors___Targets_for_the_Development_of_Drugs_to_Treat_Cognitive_Impairment_Associated_with_Schizophrenia_and_Alzheimer's_Disease_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/20166959/full_citation/Neuronal_Nicotinic_Acetylcholine_Receptors___Targets_for_the_Development_of_Drugs_to_Treat_Cognitive_Impairment_Associated_with_Schizophrenia_and_Alzheimer's_Disease_">Full Citation</a></description></item><item><title>5-HT(6) Receptor Antagonists as Potential Therapeutics for Cognitive Impairment.</title><link>http://www.unboundmedicine.com/medline/ebm/record/20166958/full_citation/5_HT_6__Receptor_Antagonists_as_Potential_Therapeutics_for_Cognitive_Impairment_</link><description>Rossé G, Schaffhauser H <br/><span class="title">5-HT(6) Receptor Antagonists as Potential Therapeutics for Cognitive Impairment. [JOURNAL ARTICLE]</span><br/><span class="source" title="Current topics in medicinal chemistry">Curr Top Med Chem 2010 Feb 18.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/20166958/abstract/5_HT_6__Receptor_Antagonists_as_Potential_Therapeutics_for_Cognitive_Impairment_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/20166958/full_citation/5_HT_6__Receptor_Antagonists_as_Potential_Therapeutics_for_Cognitive_Impairment_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/20166958/5_HT_6__Receptor_Antagonists_as_Potential_Therapeutics_for_Cognitive_Impairment_">Find Related Articles</a> </description></item></channel></rss>